SEC Comment Letter 0000000000-25-000250 to MACROGENICS INC (MGNX) (CIK 0001125345) (MGNX)

MACROGENICS INC (MGNX) (CIK 0001125345)
Date: Jan. 10, 2025 · CIK: 0001125345 · Accession: 0000000000-25-000250

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 001-36112

Date

January 10, 2025

Author

Not clearly detected

Form

UPLOAD

Company

MACROGENICS INC (MGNX) (CIK 0001125345)

Letter

January 10, 2025 James Karrels Senior Vice President and Chief Financial Officer MacroGenics, Inc. 9704 Medical Center Drive Rockville, Maryland 20850 Re:MacroGenics, Inc. Form 10-K for the Fiscal Year Ended December 31, 2023 File No. 001-36112 Dear James Karrels: We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences

Show Raw Text

January 10, 2025
James Karrels
Senior Vice President and Chief Financial Officer
MacroGenics, Inc.
9704 Medical Center Drive
Rockville, Maryland 20850
Re:MacroGenics, Inc.
Form 10-K for the Fiscal Year Ended December 31, 2023
File No. 001-36112
Dear James Karrels:
            We have completed our review of your filings. We remind you that the company and
its management are responsible for the accuracy and adequacy of their disclosures,
notwithstanding any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences

SecProbe.io